BioCentury
ARTICLE | Financial News

GenMark raises $75M in upsized follow-on

June 16, 2017 9:29 PM UTC

On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, ...

BCIQ Company Profiles

GenMark Diagnostics Inc.